News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,147 Results
Type
Article (27201)
Company Profile (62)
Press Release (363884)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (106998)
Career Advice (530)
Deals (17425)
Drug Delivery (53)
Drug Development (49847)
Employer Resources (48)
FDA (12402)
Job Trends (8718)
News (191198)
Policy (19839)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1838)
Accelerated approval (3)
Adcomms (12)
Allergies (70)
Alliances (27464)
ALS (64)
Alzheimer's disease (1078)
Antibody-drug conjugate (ADC) (45)
Approvals (12448)
Artificial intelligence (166)
Autoimmune disease (10)
Automation (4)
Bankruptcy (145)
Best Places to Work (7149)
BIOSECURE Act (5)
Biosimilars (43)
Biotechnology (39)
Bladder cancer (50)
Brain cancer (19)
Breast cancer (185)
Cancer (1378)
Cardiovascular disease (115)
Career advice (479)
Career pathing (15)
CAR-T (73)
Cell therapy (209)
Cervical cancer (13)
Clinical research (41918)
Collaboration (444)
Compensation (128)
Complete response letters (10)
COVID-19 (1595)
CRISPR (15)
C-suite (133)
Cystic fibrosis (46)
Data (1478)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (170)
Diagnostics (3596)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (14)
Drug discovery (56)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (37992)
Editorial (19)
Employer branding (6)
Employer resources (48)
Events (53400)
Executive appointments (438)
FDA (13351)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (408)
Gene editing (44)
Generative AI (12)
Gene therapy (143)
GLP-1 (422)
Government (3106)
Grass and pollen (3)
Guidances (35)
Healthcare (12492)
Huntington's disease (12)
IgA nephropathy (16)
Immunology and inflammation (49)
Indications (19)
Infectious disease (1666)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (49)
Interviews (54)
IPO (7270)
IRA (19)
Job creations (1881)
Job search strategy (432)
Kidney cancer (8)
Labor market (9)
Layoffs (183)
Leadership (7)
Legal (3696)
Liver cancer (56)
Lung cancer (225)
Lymphoma (91)
Machine learning (2)
Management (20)
Manufacturing (107)
MASH (47)
Medical device (12897)
Medtech (12900)
Mergers & acquisitions (10445)
Metabolic disorders (431)
Multiple sclerosis (54)
NASH (12)
Neurodegenerative disease (64)
Neuropsychiatric disorders (12)
Neuroscience (1437)
NextGen: Class of 2025 (4080)
Non-profit (2885)
Northern California (1344)
Now hiring (16)
Obesity (225)
Opinion (81)
Ovarian cancer (54)
Pain (62)
Pancreatic cancer (52)
Parkinson's disease (110)
Partnered (12)
Patents (111)
Patient recruitment (75)
Peanut (37)
People (35277)
Pharmaceutical (20)
Pharmacy benefit managers (11)
Phase I (12145)
Phase II (18303)
Phase III (14792)
Pipeline (689)
Policy (60)
Postmarket research (1695)
Preclinical (3950)
Press Release (18)
Prostate cancer (73)
Psychedelics (20)
Radiopharmaceuticals (186)
Rare diseases (202)
Real estate (2898)
Recruiting (16)
Regulatory (14475)
Reports (16)
Research institute (1668)
Resumes & cover letters (66)
Rett syndrome (2)
RNA editing (3)
RSV (21)
Schizophrenia (52)
Series A (67)
Series B (51)
Service/supplier (3)
Sickle cell disease (24)
Southern California (1158)
Special edition (5)
Spinal muscular atrophy (106)
Sponsored (13)
Startups (2176)
Stomach cancer (8)
Supply chain (40)
Tariffs (10)
The Weekly (9)
United States (12702)
Vaccines (369)
Venture capitalists (13)
Weight loss (146)
Women's health (17)
Worklife (5)
Date
Today (5)
Last 7 days (267)
Last 30 days (1374)
Last 365 days (19385)
2025 (5356)
2024 (20729)
2023 (23617)
2022 (31695)
2021 (34018)
2020 (32982)
2019 (29031)
2018 (22265)
2017 (19375)
2016 (18540)
2015 (21610)
2014 (16363)
2013 (13562)
2012 (14671)
2011 (14936)
2010 (13491)
Location
Africa (371)
Alabama (37)
Alaska (2)
Arizona (116)
Arkansas (10)
Asia (25047)
Australia (4088)
California (3025)
Canada (1214)
China (352)
Colorado (161)
Connecticut (168)
Delaware (106)
Europe (49165)
Florida (524)
Georgia (131)
Idaho (33)
Illinois (352)
India (13)
Indiana (225)
Iowa (2)
Japan (112)
Kansas (72)
Kentucky (13)
Louisiana (6)
Maine (27)
Maryland (617)
Massachusetts (2167)
Michigan (112)
Minnesota (261)
Mississippi (2)
Missouri (54)
Montana (18)
Nebraska (18)
Nevada (30)
New Hampshire (59)
New Jersey (1109)
New Mexico (10)
New York (954)
North Carolina (554)
North Dakota (3)
Northern California (1344)
Ohio (124)
Oklahoma (3)
Oregon (23)
Pennsylvania (815)
Puerto Rico (7)
Rhode Island (23)
South America (546)
South Carolina (18)
Southern California (1158)
Tennessee (78)
Texas (544)
Utah (105)
Virginia (74)
Washington D.C. (38)
Washington State (225)
West Virginia (3)
Wisconsin (40)
391,147 Results for "alpha tau medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
February 24, 2025
·
4 min read
Press Releases
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
April 3, 2025
·
4 min read
Press Releases
Alpha Tau to Participate in March Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
March 13, 2025
·
11 min read
Business
Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported first quarter 2024 financial results and provided a corporate update.
May 20, 2024
·
9 min read
Alpha Tau to Participate in May 2024 Investor Conferences
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.
May 1, 2024
·
1 min read
Alpha Tau to Present at the Jefferies Global Healthcare Conference
Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5 th , 2024.
May 21, 2024
·
1 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
Press Releases
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
February 3, 2025
·
4 min read
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported full year 2023 financial results and provided a corporate update.
March 7, 2024
·
11 min read
1 of 39,115
Next
